T Buroker

1.8k total citations
21 papers, 1.4k citations indexed

About

T Buroker is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, T Buroker has authored 21 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in T Buroker's work include Colorectal Cancer Treatments and Studies (10 papers), Colorectal and Anal Carcinomas (9 papers) and Gastric Cancer Management and Outcomes (8 papers). T Buroker is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Colorectal and Anal Carcinomas (9 papers) and Gastric Cancer Management and Outcomes (8 papers). T Buroker collaborates with scholars based in United States and Canada. T Buroker's co-authors include V. K. Vaitkevicius, Laurence H. Baker, Jerome P. Horwitz, Bryden Considine, James E. Krook, J A Mailliard, Vainutis K. Vaitkevicius, N Nigro, Dean H. Gesme and James B. Gerstner and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

T Buroker

21 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T Buroker United States	18	835	603	531	170	154	21	1.4k
L Herrera United States	12	1.1k 1.3×	398 0.7×	407 0.8×	488 2.9×	206 1.3×	28	1.5k
Robert M. OʼBryan United States	18	960 1.1×	301 0.5×	636 1.2×	216 1.3×	215 1.4×	44	1.5k
Steven E. Vogl United States	21	749 0.9×	458 0.8×	554 1.0×	195 1.1×	229 1.5×	55	1.4k
V. Izraël France	16	946 1.1×	259 0.4×	325 0.6×	298 1.8×	122 0.8×	37	1.4k
K. Bertelsen Denmark	25	849 1.0×	1.1k 1.8×	296 0.6×	261 1.5×	181 1.2×	70	2.3k
John D. Bonnet United States	22	1.0k 1.2×	202 0.3×	264 0.5×	147 0.9×	620 4.0×	41	1.7k
Roland Sonntag Switzerland	20	471 0.6×	732 1.2×	422 0.8×	107 0.6×	485 3.1×	48	1.5k
J J Lokich United States	5	1.4k 1.7×	363 0.6×	486 0.9×	244 1.4×	163 1.1×	6	1.6k
G. Comella Italy	21	978 1.2×	209 0.3×	435 0.8×	146 0.9×	235 1.5×	70	1.2k
J. F. Pringle Canada	18	480 0.6×	363 0.6×	310 0.6×	89 0.5×	155 1.0×	22	1.3k

Countries citing papers authored by T Buroker

Since Specialization

Citations

This map shows the geographic impact of T Buroker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Buroker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Buroker more than expected).

Fields of papers citing papers by T Buroker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Buroker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Buroker. The network helps show where T Buroker may publish in the future.

Co-authorship network of co-authors of T Buroker

This figure shows the co-authorship network connecting the top 25 collaborators of T Buroker. A scholar is included among the top collaborators of T Buroker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Buroker. T Buroker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

D’Andre, Stacy D., Daniel J. Sargent, S. Stephen, et al.. (2005). 5-Fluorouracil–Based Chemotherapy for Advanced Colorectal Cancer in Elderly Patients: A North Central Cancer Treatment Group Study. Clinical Colorectal Cancer. 4(5). 325–331. 36 indexed citations

Buroker, T, M J O'Connell, Harry S. Wieand, et al.. (1994). Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer.. Journal of Clinical Oncology. 12(1). 14–20. 248 indexed citations

Culver, Kenneth W., et al.. (1994). Gene Therapy for the Treatment of Malignant Brain Tumors with In Vivo Tumor Transduction with the Herpes Simplex Thymidine Kinase Gene/Ganciclovir System. Iowa Methodist Medical Center, Des Moines, Iowa. Human Gene Therapy. 5(3). 343–379. 80 indexed citations

Creagan, Edward T., Donald I. Twito, Daniel J. Schaid, et al.. (1991). A randomized prospective assessment of recombinant leukocyte A human interferon with or without aspirin in advanced renal adenocarcinoma.. Journal of Clinical Oncology. 9(12). 2104–2109. 42 indexed citations

Buroker, T, C G Moertel, Thomas R. Fleming, et al.. (1985). A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.. Journal of Clinical Oncology. 3(12). 1624–1631. 90 indexed citations

Leichman, Lawrence, Norman D. Nigro, Vainutis K. Vaitkevicius, et al.. (1985). Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy. The American Journal of Medicine. 78(2). 211–215. 143 indexed citations

Steiger, Zwi, R H Franklin, Robert F. Wilson, et al.. (1981). Eradication and palliation of squamous cell carcinoma of the esophagus with chemotherapy, radiotherapy, and surgical therapy. Journal of Thoracic and Cardiovascular Surgery. 82(5). 713–719. 93 indexed citations

Nigro, N, et al.. (1981). Combined therapy for cancer of the anal canal. Diseases of the Colon & Rectum. 24(2). 73–75. 106 indexed citations

Buroker, T, C. W. Groppe, Joseph D. McCracken, et al.. (1979). 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer. A Southwest oncology group study. Cancer. 44(4). 1215–1221. 40 indexed citations

10.

Buroker, T, Fernando Padilla, C. W. Groppe, et al.. (1979). Phase ii evaluation of ftorafur in previously untreated colorectal cancer: A southwest oncology group study. Cancer. 44(1). 48–51. 25 indexed citations

11.

Buroker, T, et al.. (1978). Mitomycin‐C alone and in combination with infused 5‐fluorouracil in the treatment of disseminated gastrointestinal carcinomas. Medical and Pediatric Oncology. 4(1). 35–42. 19 indexed citations

12.

Buroker, T, C. W. Groppe, Joseph D. McCracken, et al.. (1978). 5FU infusion with mitomycin-C versus 5FU infusion with methyl-CCNU in the treatment of advanced colon cancer.A southwest oncology group study. Cancer. 42(3). 1228–1233. 36 indexed citations

13.

Buroker, T, et al.. (1977). Phase II clinical trial of ftorafur in 5-fluorouracil-refractory colorectal cancer.. PubMed. 61(8). 1579–80. 8 indexed citations

14.

Buroker, T, et al.. (1977). Phase I trial of ftorafur combined with mitomycin C or methyl-CCNU in gastrointestinal cancers.. PubMed. 61(3). 463–7. 2 indexed citations

15.

Buroker, T, et al.. (1977). Combined therapy for cancer of the anal canal. Diseases of the Colon & Rectum. 20(8). 677–678. 68 indexed citations

16.

Buroker, T, et al.. (1976). Hepatic artery infusion of 5-FUDR after prior systemic 5-fluorouracil.. PubMed. 60(9). 1277–9. 18 indexed citations

17.

Buroker, T, et al.. (1976). Combination preoperative radiation and chemotherapy in adenocarcinoma of the rectum. Diseases of the Colon & Rectum. 19(8). 660–663. 26 indexed citations

18.

Singhakowinta, Amnuay, et al.. (1976). Estrogen Receptor and Natural Course of Breast Cancer. Annals of Surgery. 183(1). 84–88. 60 indexed citations

19.

Buroker, T, et al.. (1975). Response of patients with carcinoma of the breast to hormonal therapy and combination chemotherapy.. PubMed. 141(2). 232–4. 5 indexed citations

20.

Samson, Michael K., et al.. (1975). Acquired hypertrichosis lanuginosa.Report of two new cases and a review of the literature. Cancer. 36(4). 1519–1521. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact